brofaromine has been researched along with Panic Disorder in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| den Boer, JA; Slaap, BR; van Vliet, IM; Westenberg, HG | 3 |
| Gimbrett, R; Priest, RG; Roberts, M; Steinert, J | 1 |
| Den Boer, JA; van Vliet, IM; Westenberg, HG | 1 |
| Bakish, D | 1 |
| Bakish, D; Bowen, R; D'Souza, J; Saxena, BM | 1 |
| Stein, MB | 1 |
| Garcia-Borreguero, D; Holsboer, F; Krieg, JC; Lauer, CJ; Ozdaglar, A; Wiedemann, K | 1 |
1 review(s) available for brofaromine and Panic Disorder
| Article | Year |
|---|---|
Medication treatments for panic disorder and social phobia.
Topics: Antidepressive Agents, Tricyclic; Benzamides; Benzodiazepines; Citalopram; Clinical Trials as Topic; Clomipramine; Clonazepam; Dose-Response Relationship, Drug; Female; Humans; Male; Moclobemide; Monoamine Oxidase Inhibitors; Panic Disorder; Paroxetine; Piperidines; Recurrence; Selective Serotonin Reuptake Inhibitors; Social Behavior Disorders | 1998 |
6 trial(s) available for brofaromine and Panic Disorder
| Article | Year |
|---|---|
Phobic symptoms as predictors of nonresponse to drug therapy in panic disorder patients (a preliminary report).
Topics: Adult; Agoraphobia; Double-Blind Method; Female; Fluvoxamine; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Panic; Panic Disorder; Personality Inventory; Phobic Disorders; Piperidines; Prognosis; Treatment Outcome | 1995 |
MAO inhibitors in panic disorder: clinical effects of treatment with brofaromine. A double blind placebo controlled study.
Topics: Adult; Agoraphobia; Double-Blind Method; Fear; Female; Follow-Up Studies; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Panic Disorder; Piperidines; Psychiatric Status Rating Scales | 1993 |
The use of the reversible monoamine oxidase-A inhibitor brofaromine in social phobia complicated by panic disorder with or without agoraphobia.
Topics: Adult; Agoraphobia; Humans; Male; Monoamine Oxidase Inhibitors; Panic Disorder; Phobic Disorders; Piperidines | 1994 |
Reversible monoamine oxidase-A inhibitors in panic disorder.
Topics: Agoraphobia; Clomipramine; Double-Blind Method; Humans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Panic Disorder; Piperidines; Psychiatric Status Rating Scales | 1993 |
A double-blind comparative study of brofaromine and fluvoxamine in outpatients with panic disorder.
Topics: Adult; Anti-Anxiety Agents; Double-Blind Method; Female; Fluvoxamine; Headache; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Nausea; Panic Disorder; Piperidines; Selective Serotonin Reuptake Inhibitors | 1996 |
MHPG and heart rate as correlates of nonresponse to drug therapy in panic disorder patients. A preliminary report.
Topics: Adult; Biomarkers; Blood Pressure; Double-Blind Method; Female; Fluvoxamine; Heart Rate; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase Inhibitors; Panic Disorder; Piperidines; Selective Serotonin Reuptake Inhibitors; Treatment Failure | 1996 |
2 other study(ies) available for brofaromine and Panic Disorder
| Article | Year |
|---|---|
Reversible and selective inhibitors of monoamine oxidase A in mental and other disorders.
Topics: Alzheimer Disease; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Benzamides; Humans; Moclobemide; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Panic Disorder; Phobic Disorders; Piperidines | 1995 |
Brofaromine in panic disorder: a pilot study with a new reversible inhibitor of monoamine oxidase-A.
Topics: Adult; Agoraphobia; Female; Humans; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Panic Disorder; Piperidines; Psychiatric Status Rating Scales | 1992 |